donepezil has been researched along with thioperamide in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, Y; Huang, S; Huang, W; Li, J; Sheng, R; Shi, Y; Tang, L; Wu, P; Xu, L; Zhou, N | 1 |
Chen, C; Fu, J; Hu, M; Li, X; Shao, S; Shi, G; Wang, D; Wu, S; Zhang, D; Zhang, T; Zhou, Y | 1 |
Arribas, RL; Chabchoub, F; de Los Ríos, C; Demougeot, C; Diez-Iriepa, D; Egea, J; Godyń, J; Głuch-Lutwin, M; Iriepa, I; Ismaili, L; Kiec-Kononowicz, K; Kobrlova, T; Malawska, B; Malek, R; Marco-Contelles, J; Moraleda, I; Mordyl, B; Palomino-Antolin, A; Panek, D; Siwek, A; Soukup, O; Totoson, P | 1 |
Barbier, A; Carruthers, NI; Dai, H; Iinuma, K; Jia, F; Kato, M; Lovenberg, TW; Okamura, N; Okuda, T; Sakurai, E; Xu, A; Yanai, K | 1 |
Aluisio, L; Boggs, JD; Bonaventure, P; Fraser, IC; Galici, R; Lord, B; Lovenberg, TW | 1 |
5 other study(ies) available for donepezil and thioperamide
Article | Year |
---|---|
Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H₃R and BACE 1 inhibitory activities.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Cholinesterase Inhibitors; Histamine H3 Antagonists; Humans; Kinetics; Ligands; Models, Molecular; Quinoxalines; Receptors, Histamine H3; Structure-Activity Relationship | 2011 |
Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Blood-Brain Barrier; Butyrylcholinesterase; Cell Line; Cell Survival; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Humans; Inflammation; Isoflavones; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Models, Molecular; Molecular Structure; Neuroprotective Agents; Receptors, Histamine H3; Structure-Activity Relationship | 2019 |
New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H
Topics: Alzheimer Disease; Animals; Calcium Channel Blockers; Cholinesterase Inhibitors; Humans; Memory Disorders; Mice; Neuroblastoma; Neuroprotective Agents; Receptors, Histamine H3; Small Molecule Libraries; Tumor Cells, Cultured; Vasodilator Agents | 2019 |
Effects of histamine H(3) antagonists and donepezil on learning and mnemonic deficits induced by pentylenetetrazol kindling in weanling mice.
Topics: Animals; Avoidance Learning; Convulsants; Donepezil; Electric Stimulation; Female; Histamine Antagonists; Indans; Kindling, Neurologic; Learning Disabilities; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Nootropic Agents; Pentylenetetrazole; Piperidines; Recognition, Psychology | 2006 |
JNJ-10181457, a selective non-imidazole histamine H(3) receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognition.
Topics: Acetylcholine; Animals; Anticonvulsants; Brain; Cholinesterase Inhibitors; Cognition; Conditioning, Operant; Donepezil; Drinking Behavior; Drug Evaluation, Preclinical; Histamine Agonists; Histamine Antagonists; Imidazoles; Indans; Learning; Microdialysis; Morpholines; Muscarinic Antagonists; Nootropic Agents; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Histamine H3; Scopolamine; Synaptic Transmission; Thiourea | 2009 |